| |
| |
|
| Insider
Information: |
Arroyo Santiago |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
41,750 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,685 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,750 |
|
|
| Total
Value |
$3,685 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
SVP, Chief Medical Off... |
2020-10-01 |
0 |
2017-06-20 |
0 |
Premium* |
|
|
Marinus Pharmaceuticals Inc |
MRNS |
Director |
2022-02-04 |
2,750 |
2022-02-04 |
0 |
Premium* |
|
|
Bicycle Therapeutics Ltd |
BCYC |
|
2024-02-06 |
39,000 |
2024-01-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
36,000 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
58,335 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-04-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,000) |
21,803 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-10-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,000 |
33,272 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
3,500 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
27,265 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
34,576 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-04-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
30,720 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
44,106 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,350 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
30,340 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(26) |
0 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
Director |
– • – |
2022-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
2,750 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Chief Development Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,340 |
17,340 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
CHIEF DEVELOPMENT OFFICER |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
21,660 |
39,000 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-02-13 |
4 |
AS |
$12.70 |
$98,323 |
D/D |
(7,742) |
50,593 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-15 |
4 |
A |
$12.76 |
$516,591 |
D/D |
32,656 |
78,194 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-21 |
4 |
A |
$12.76 |
$516,591 |
D/D |
32,656 |
61,435 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-29 |
4 |
OE |
$12.76 |
$516,591 |
D/D |
32,656 |
41,504 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-08-04 |
4 |
OE |
$12.76 |
$516,591 |
D/D |
32,656 |
34,636 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-02-14 |
4 |
AS |
$13.10 |
$34,990 |
D/D |
(2,671) |
47,922 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-10-18 |
4 |
AS |
$13.83 |
$87,378 |
D/D |
(6,318) |
26,954 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-04-09 |
4 |
AS |
$15.00 |
$121,785 |
D/D |
(8,119) |
39,803 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-04-29 |
4 |
AS |
$15.00 |
$37,965 |
D/D |
(2,531) |
19,272 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2019-11-07 |
4 |
S |
$15.91 |
$428,838 |
D/D |
(26,954) |
0 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
